Scholars Central

Conference abstractPublished 3 Sep 2015

Does new approach regarding reversing adipocyte inflammation in obesity really worthy?

Authors: U Deniz Dincer

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Visceral fat is thought to be the source of adiposopathy, which is characterised by chronic inflammation and necrosis. It produces and releases many bioactive peptides named adipokines, which play important roles in energy production, vascular homeostasis, immunity and metabolic syndrome. When healthy adipocytes are transformed to “sick adipocytes”, all the hormones, cytokines, chemokines and growth factors released from fat may change. Thus, a new perspective related to developing new approach against obesity and metabolic syndrome focuses on “reversing inflammation in adipose tissue”, which could break the link between inflammation and adiposopathy-associated complications. When clinicians and scientists aim to create an “avant-garde” human body, obesity cannot include on that picture; it is more than aesthetic outfit but certainly related associated complications. Reversing adipocyte inflammation is a “new therapeutic approach” which could reverse adiposity-associated complications in metabolic syndrome, type II diabetes and atherosclerotic cardiovascular disease.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Obesity & Weight Loss Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Obesity & Weight Loss Therapy
  • SubjectObesity & Weight Management
  • BylineArticles whose byline prints “U Deniz Dincer”